dc.contributor.author |
Kruck, Stephan |
de_DE |
dc.contributor.author |
Stenzl, Arnulf |
de_DE |
dc.contributor.author |
Bedke, Jens |
de_DE |
dc.date.accessioned |
2014-07-30T15:13:09Z |
|
dc.date.available |
2014-07-30T15:13:09Z |
|
dc.date.issued |
2014 |
de_DE |
dc.identifier.issn |
0724-4983 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/55033 |
|
dc.language.iso |
en |
en |
dc.publisher |
Springer |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1007/s00345-013-1096-1 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
How far is the horizon? From current targets to future drugs in advanced renal cancer |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140610213910_00894 |
de_DE |
utue.publikation.seiten |
69-77 |
de_DE |
utue.personen.roh |
Kruck, Stephan |
de_DE |
utue.personen.roh |
Merseburger, Axel S. |
de_DE |
utue.personen.roh |
Stenzl, Arnulf |
de_DE |
utue.personen.roh |
Bedke, Jens |
de_DE |
dcterms.isPartOf.ZSTitelID |
World Journal of Urology |
de_DE |
dcterms.isPartOf.ZS-Issue |
1 |
de_DE |
dcterms.isPartOf.ZS-Volume |
32 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |